Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Ultimovacs plans to raise $82 million in IPO to develop cancer drug

      Ultimovacs plans to raise $82 million in IPO to develop cancer drug

      Medical Dialogues Bureau4 Dec 2018 9:15 AM IST
      OSLO: Norway biotech company Ultimovacs plans to raise around 700 million Norwegian crowns ($82 million) in an initial public offering in early 2019...
      Chairman Anders Lonner dead: Karo Pharma

      Chairman Anders Lonner dead: Karo Pharma

      Medical Dialogues Bureau4 Dec 2018 9:00 AM IST
      STOCKHOLM: Speciality pharma firm Karo Pharma's Chairman Anders Lonner has died, the company said in a statement recently."Anders Lonner has suddenly...
      With Gluten or Gluten Free : Drugmakers will soon have to likely declare on labelling the presence of Gluten

      With Gluten or Gluten Free : Drugmakers will soon have to likely declare on labelling the presence of Gluten

      Medical Dialogues Bureau3 Dec 2018 5:04 PM IST
      Drugmakers may be asked to declare whether a drug is gluten-freeNew Delhi: Following the move to have labelling identifying the presence of gluten in...
      Launch of User Manual on SUGAM portal: CDSCO

      Launch of User Manual on SUGAM portal: CDSCO

      Medical Dialogues Bureau2 Dec 2018 12:00 PM IST
      New Delhi: Through a public notice released on 29.11.2018 Central Drugs Standard Control Organisation(CDSCO) has announced the launch of a User...
      FDA nods to Truxima-first biosimilar to Roche cancer drug Rituxan

      FDA nods to Truxima-first biosimilar to Roche cancer drug Rituxan

      Medical Dialogues Bureau2 Dec 2018 9:20 AM IST
      New Delhi: Celltrion Inc's Truxima on Wednesday became the first biosimilar to Roche Holding AG's $7-billion-per-year cancer drug Rituxan to be...
      Biotech company Moderna expects to raise up to around 36 crore in Initial Public Offering

      Biotech company Moderna expects to raise up to around 36 crore in Initial Public Offering

      Medical Dialogues Bureau2 Dec 2018 9:01 AM IST
      New Delhi: Biotech company Moderna Inc recently said it expects to raise up to $521.7 million(Rs 36,39,90,09,000) in its initial public offering,...
      Application for Bulk Vaccine to be filed mandatorily through SUGAM: CDSCO

      Application for Bulk Vaccine to be filed mandatorily through SUGAM: CDSCO

      Medical Dialogues Bureau1 Dec 2018 10:35 AM IST
      It is now decided that no physical application for Bulk Vaccine will be accepted and all applications should be necessarily filed through SUGAM...
      Merck increases price of five drugs including Keytruda in November

      Merck increases price of five drugs including Keytruda in November

      Medical Dialogues Bureau1 Dec 2018 9:15 AM IST
      NEW YORK: Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 per cent and 6 per cent,...
      Zydus Cadila gets USFDA nod to market generic Lansoprazole tablets

      Zydus Cadila gets USFDA nod to market generic Lansoprazole tablets

      Medical Dialogues Bureau1 Dec 2018 9:05 AM IST
      New Delhi: Drug firm Zydus Cadila has recently said it has received the final nod from the US health regulator to market generic Lansoprazole tablets...
      Unilever CEO retires , replaced by insider Jope

      Unilever CEO retires , replaced by insider Jope

      Medical Dialogues Bureau1 Dec 2018 9:00 AM IST
      LONDON: Unilever's Chief Executive Paul Polman will step down next month after 10 years in the job, leaving insider Alan Jope to step into his shoes...
      Should Surgical gowns and drapes come under Drugs and Cosmetics Act? CDSCO invites Public Comments

      Should Surgical gowns and drapes come under Drugs and Cosmetics Act? CDSCO invites Public Comments

      Medical Dialogues Bureau30 Nov 2018 1:13 PM IST
      New Delhi: Through a recent public notice, the Central Drugs Standard Control Organisation(CDSCO) has informed about the proposal of bringing surgical...
      SEBI nod to Inventia Healthcare for Initial Public Offering

      SEBI nod to Inventia Healthcare for Initial Public Offering

      Medical Dialogues Bureau30 Nov 2018 10:00 AM IST
      New Delhi: Inventia Healthcare received markets regulator Security and Exchange Board of India(Sebi's) approval to float initial public...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok